OptimizeRx(OPRX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 OptimizeRx Reports First Quarter 2024 Financial Results - Q1 revenue of $19.7 million, increasing 51% year-over-year - Q1 gross profit increased 64% year-over-year to$ 12.2 million with a gross margin of 62% - Won 9 DAAP deals during Q1 WALTHAM, Mass. – May 14, 2024 – OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the three ...